Therapeutic Plasma Exchange Combined with Intravenous Immunoglobin Reduces Biological Age
Summary by News Medical
3 Articles
3 Articles
All
Left
Center
2
Right
Therapeutic plasma exchange combined with intravenous immunoglobin reduces biological age
A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobin reduced biological age on average by 2.6 years, as measured by multi-omic biomarkers.
·United States
Read Full ArticleClinical trial demonstrates the impact of therapeutic plasma exchange on biological age
A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omic biomarkers. Results of the single-blind, placebo-controlled trial are published in Aging Cell.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage